Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.
Download your FREE Options Strategy Guide Today.
David J. Moss, insider at INmune Bio

David J. Moss Insider Information

CFO of INmune Bio
Mr. Moss has been CFO since the formation of the Company in September 2015. Mr. Moss has founded, funded and taken public various companies in a variety of industries since 1995. Mr. Moss was a founding investor in Reliant Service Group LLC, which was acquired in 2015 by a leading private equity firm. Mr. Moss previously served as Managing Director, Corporate Finance for a New York-based securities firm, where he advised companies on corporate strategy, financings and business development. Prior to that, he served as Managing Partner at a Seattle-based venture capital firm. Mr. Moss holds an MBA from Rice University and a BA in Economics from the University of California, San Diego.

What is David J. Moss' net worth?

The estimated net worth of David J. Moss is at least $10.18 million as of May 26th, 2022. Mr. Moss owns 1,244,651 shares of INmune Bio stock worth more than $10,181,245 as of June 28th. This net worth approximation does not reflect any other investments that Mr. Moss may own. Additionally, Mr. Moss receives an annual salary of $384,000.00 as CFO at INmune Bio. Learn More about David J. Moss' net worth.

How old is David J. Moss?

Mr. Moss is currently 52 years old. There are 2 older executives and no younger executives at INmune Bio. The oldest executive at INmune Bio is Dr. Raymond Joseph Tesi M.D., Co-Founder, Pres, CEO, Chief Medical Officer & Chairman, who is 66 years old. Learn More on David J. Moss' age.

What is David J. Moss' salary?

As the CFO of INmune Bio, Inc., Mr. Moss earned a total compensation package of $300,000.00 in 2020. Mr. Moss earned a salary of $300,000.00, and no other miscellaneous compensation. The highest earning executive at INmune Bio is Dr. Raymond Joseph Tesi M.D., Co-Founder, Pres, CEO, Chief Medical Officer & Chairman, who commands a salary of $455,000.00 per year. Learn More on David J. Moss' salary.

How do I contact David J. Moss?

The corporate mailing address for Mr. Moss and other INmune Bio executives is 1200 PROSPECT STREET SUITE 525, LA JOLLA CA, 92037. INmune Bio can also be reached via phone at (858) 964-3720 and via email at [email protected] Learn More on David J. Moss' contact information.

Has David J. Moss been buying or selling shares of INmune Bio?

In the last ninety days, David J. Moss has bought $48,279.00 in shares of INmune Bio stock. As an example of a recent trade by , 0 shares of the stock in a transaction on Tuesday, June 28th. Learn More on David J. Moss' trading history.

Who are INmune Bio's active insiders?

INmune Bio's insider roster includes Mark Lowdell (Insider), David Moss (CFO), Timothy Schroeder (Director), and Raymond Tesi (CEO). Learn More on INmune Bio's active insiders.

Are insiders buying or selling shares of INmune Bio?

During the last twelve months, INmune Bio insiders bought shares 2 times. They purchased a total of 14,000 shares worth more than $88,662.00. During the last twelve months, insiders at the sold shares 15 times. They sold a total of 106,153 shares worth more than $2,329,859.36. The most recent insider tranaction occured on May, 26th when CEO Raymond Joseph Tesi bought 6,300 shares worth more than $40,383.00. Insiders at INmune Bio own 34.2 % of the company. Learn More about insider trades at INmune Bio.

Information on this page was last updated on 5/26/2022.

David J. Moss Insider Trading History at INmune Bio

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/26/2022Buy7,700$6.27$48,279.001,244,651View SEC Filing Icon  
11/3/2021Sell1,025$20.00$20,500.00View SEC Filing Icon  
10/27/2021Sell2,079$20.00$41,580.00View SEC Filing Icon  
10/25/2021Sell13$20.00$260.00View SEC Filing Icon  
10/22/2021Sell1,142$20.00$22,840.00View SEC Filing Icon  
7/7/2021Sell8,698$20.01$174,046.98View SEC Filing Icon  
8/20/2019Buy3,000$5.65$16,950.00View SEC Filing Icon  
5/6/2019Buy5,000$9.00$45,000.00View SEC Filing Icon  
See Full Table

David J. Moss Buying and Selling Activity at INmune Bio

This chart shows David J Moss's buying and selling at INmune Bio by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

INmune Bio Company Overview

INmune Bio logo
INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on treating women with relapse refractory ovarian carcinoma and patients with high-risk myelodysplastic syndrome; INB03, an immunotherapy that treats patients with hematologic malignancies and solid tumors; and XPro1595 for the treatment of Alzheimer's disease. The company has license agreements with Xencor, Inc.; Immune Ventures, LLC; University of Pittsburg; and University College London. INmune Bio, Inc. was incorporated in 2015 and is headquartered in Boca Raton, Florida.
Read More

Today's Range

Now: $8.18
Low: $8.05
High: $9.00

50 Day Range

MA: $7.22
Low: $5.48
High: $8.63

2 Week Range

Now: $8.18
Low: $4.63
High: $30.37


79,274 shs

Average Volume

145,137 shs

Market Capitalization

$146.80 million

P/E Ratio


Dividend Yield



Former Lawyer Went From $50K To $5.3M Trading Options
Slaving away for 70 hrs a week as a lawyer in Chicago, I was miserable.

I ran into guys who worked the trading floor at the local exchange. I began trading the same way they did. I started out with $50K (much more than I needed, actually).

I grew my $50K into $5.3M
I'll show you how I did it here.